7th Eurasian Hematology Oncology Summit

 

7th Eurasian Hematology Oncology Summit
R

Management of Ph+ Leukemia During COVID-19 Pandemic: Is Induction / Consolidation Dasatinib + Blinatumomab the Optimal Solution?

By 7th Eurasian Hematology Oncology Summit FEATURING Robin Foa
By 7th Eurasian Hematology Oncology Summit FEATURING Robin Foa
14 views
December 15, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

15:58
Amgen Hematology

Insights on Proteasome Inhibitor Combinations at First Relapse in Mu…

Feat. M. Levy
COVID-19
19:08

Management of Ph+ Leukemia During COVID-19 Pandemic: Is Induction / …

7th Eurasian Hematology Oncology Summit

R. Foa

14 views
17:27

How SARS-CoV-2 Affects Cancer Patients: Epidemiology, Behavior, Symp…

7th Eurasian Hematology Oncology Summit

R. Chemaly

6 views
16:36

CLL Management During the COVID-19 Pandemic: New Strategies and Cons…

7th Eurasian Hematology Oncology Summit

R. Foa

22 views